April 30, 2024
Breaking news: Committee favors approval of under-the-skin Ocrevus in Europe
- /
By: Andrea Lobo, PhD — Written – April 30, 2024 New formulation recommended by CHMP would be faster, easier for…
MS Views and News, empowers those affected by Multiple Sclerosis (MS) with educational information, resources and services. Please scroll downward to find articles or videos of interest, then click to open the document or video.
April 30, 2024
A Smoldering Process: A New Way of Thinking about Multiple Sclerosis
- /
- /
- /
Published on: October 4, 2023 Our understanding of the biology of multiple sclerosis is changing. New research sheds light on…
April 30, 2024
PET scans reveal ‘smoldering’ inflammation in patients with MS
- /
- /
April 26, 2024 A new study suggests positron emission tomography brain scans could reveal hidden inflammation in patients with multiple…
April 30, 2024
What Are the Physiological Changes of Multiple Sclerosis (MS)?
- /
- /
MS causes white blood cells to attack or injure myelin and other parts of the CNS (central nervous system). The…
April 30, 2024
How to Spot the Signs of an MS Flare
- /
- /
When new multiple sclerosis symptoms crop up or old ones worsen, you may be having an MS relapse. By Chris…
April 19, 2024
Press Release: New 48-week frexalimab phase 2 data support potential for high sustained efficacy in multiple sclerosis (sanofi.com)
- /
- /
April 17, 2024 Download PDF New 48-week frexalimab phase 2 data support potential for high sustained efficacy in multiple sclerosis…
April 19, 2024
Press Release: TG Therapeutics Awarded National Contract by the Department of Veterans Affairs for BRIUMVI as the Preferred Anti-CD20 for Relapsing Forms of Multiple Sclerosis
- /
Apr 18, 2024 PDF Version NEW YORK, April 18, 2024 (GLOBE NEWSWIRE) — TG Therapeutics, Inc. (NASDAQ: TGTX), announced that…
April 17, 2024
Apr 17, 2024 – Press Release: Novartis Kesimpta® six-year efficacy data show substantial benefits in recently diagnosed treatment-naïve people with relapsing multiple sclerosis
- /
- /
Apr 17, 2024 EAST HANOVER, N.J., April 17, 2024 — Novartis today announced data from the ALITHIOS open-label extension study showing sustained…
April 17, 2024
Apr 16, 2024 – Press Release: Genentech’s Subcutaneous Ocrevus One-Year Data Demonstrates Near-Complete Suppression of Clinical Relapses and Brain Lesions in Patients With Progressive and Relapsing Forms of MS
- /
- /
Media / Press Releases Tuesday, Apr 16, 2024 Results from the Phase III study showed that subcutaneous (SC) injection was consistent with…
April 11, 2024
OrCam Assistive Smart Cameras For Impaired Sight and Reading Difficulties
- /
Do you or someone you know have difficulty seeing or reading? The most advanced tool for vision loss and reading…
